Advertisement

Associations of Later-Life Education, the BDNF Val66Met Polymorphism and Cognitive Change in Older Adults

  • David D. WardEmail author
  • M. J. Summers
  • M. J. Valenzuela
  • V. K. Srikanth
  • J. J. Summers
  • A. E. King
  • K. Ritchie
  • A. L. Robinson
  • J. C. Vickers
Brief Reports

Abstract

In 358 participants of the Tasmanian Healthy Brain Project, we quantified the cognitive consequences of engaging in varying loads of university-level education in later life, and investigated whether or not BDNF Val66Met affected outcomes. Assessment of neuropsychological, health, and psychosocial function was undertaken at baseline, 12-month, and 24-month follow-up. Education load was positively associated with change in language processing performance, but this effect did not reach statistical significance (P = 0.064). The BDNF Val66Met polymorphism significantly moderated the extent to which education load was associated with improved language processing (P = 0.026), with education load having a significant positive relationship with cognitive change in BDNF Met carriers but not in BDNF Val homozygotes. In older adults who carry BDNF Met, engaging in university-level education improves language processing performance in a load-dependent manner.

Key words

Education BDNF cognitive university intervention 

Notes

Acknowledgments

We thank Dr Nikki Saunders for project management, Mr Aidan D. Bindoff for statistical advice, Mr Graeme McCormack for assistance with data collection, and Ms Monica Antel for administrative support. Each of these individuals was affiliated with the Wicking Dementia Research & Education Centre, University of Tasmania.

Funding: Study Funded by the National Health and Medical Research Council (project grant 1003645, 1108794) and the JO and JR Wicking Trust (Equity Trustees). The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; in the preparation of the manuscript; or in the review or approval of the manuscript.

Conflict of interest disclosure: David D. Ward — Reports no disclosures; Mathew J. Summers — Reports personal fees from Eli Lilly (Australia) Pty. Ltd., grants from Novotech Pty. Ltd., outside the submitted work; Michael J. Valenzuela — Reports no disclosures; Velandai K. Srikanth — Reports no disclosures; Jeffery J. Summers — Reports no disclosures; Anna E. King — Reports no disclosures; Karen Ritchie — Reports no disclosures; Andrew L. Robinson — Reports no disclosures; James C. Vickers — Reports no disclosures

Ethical standards: This research was conducted in full compliance of NHMRC (Australia) Human Research Guidelines, was overseen by the Human Research Ethics Committee (Tasmania) Network, and complied with the APA ethics standards and the ethical rules for human experimentation as stated in the Declaration of Helsinki.

Supplementary material

42414_2019_90_MOESM1_ESM.docx (47 kb)
Supplementary Table. Mean estimates for 24-month cognitive performance (N = 358)

References

  1. 1.
    Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer’s disease. Ther Adv Neurol Disord. 2013;6: 19–33. doi: https://doi.org/10.1177/1756285612461679 CrossRefGoogle Scholar
  2. 2.
    Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley, J., Ames, D., et al. Dementia prevention, intervention, and care. The Lancet. 2017;390: 2673–2734. doi: https://doi.org/10.1016/S0140-6736(17)31363-6 CrossRefGoogle Scholar
  3. 3.
    Langa KM, Larson EB, Crimmins EM, Faul JD, Levine DA, Kabeto MU, et al. A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017;177: 51. doi: https://doi.org/10.1001/jamainternmed.2016.6807 CrossRefGoogle Scholar
  4. 4.
    Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112: 257–269CrossRefGoogle Scholar
  5. 5.
    Pattwell SS, Bath KG, Perez-Castro R, Lee FS, Chao MV, Ninan I. The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex. Journal of Neuroscience. 2012;32: 2410–2421. doi: https://doi.org/10.1523/JNEUROSCI.5205-11.2012 CrossRefGoogle Scholar
  6. 6.
    Gomar JJ, Conejero-Goldberg C, Huey ED, Davies P, Goldberg TE, Alzheimer’s Disease Neuroimaging Initiative. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer’s disease. Neurobiology of Aging. 2016;39: 165–173. doi: https://doi.org/10.1016/j.neurobiolaging.2015.12.004 CrossRefGoogle Scholar
  7. 7.
    Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, et al. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer’s disease. Neurobiology of Aging. 2013;34: 2457–2464. doi: https://doi.org/10.1016/j.neurobiolaging.2013.05.006 CrossRefGoogle Scholar
  8. 8.
    Summers MJ, Saunders NLJ, Valenzuela MJ, Summers JJ, Ritchie K, Robinson A, et al. The Tasmanian Healthy Brain Project (THBP): a prospective longitudinal examination of the effect of university-level education in older adults in preventing age-related cognitive decline and reducing the risk of dementia. Int Psychogeriatr. 2013;25: 1145–1155. doi: https://doi.org/10.1017/S1041610213000380 CrossRefGoogle Scholar
  9. 9.
    Ward DD, Summers MJ, Saunders NL, Vickers JC. Modeling cognitive reserve in healthy middle-aged and older adults: the Tasmanian Healthy Brain Project. Int Psychogeriatr. 2015;27: 579–589. doi: https://doi.org/10.1017/S1041610214002075 CrossRefGoogle Scholar
  10. 10.
    Donohoe GG, Salomäki A, Lehtimäki T, Pulkki K, Kairisto V. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clin Chem. 1999;45: 143–146.PubMedGoogle Scholar
  11. 11.
    Sheikh HI, Hayden EP, Kryski KR, Smith HJ, Singh SM. Genotyping the BDNF rs6265 (val66met) polymorphism by one-step amplified refractory mutation system PCR. Psychiatric Genetics. 2010;20: 109–112. doi: https://doi.org/10.1097/YPG.0b013e32833a2038 PubMedPubMedCentralGoogle Scholar
  12. 12.
    Ward DD, Andel R, Saunders NL, Thow ME, Klekociuk SZ, Bindoff AD, et al. The BDNF Val66Met polymorphism moderates the effect of cognitive reserve on 36-month cognitive change in healthy older adults. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2017;3: 323–331. doi: https://doi.org/10.1016/j.trci.2017.04.006 Google Scholar
  13. 13.
    Thow ME, Summers MJ, Summers JJ, Saunders NL, Vickers JC. Variations in the APOE allele or BDNF Val66Met polymorphism are not associated with changes in cognitive function following a tertiary education intervention in older adults: the Tasmanian Healthy Brain Project. Neurobiology of Aging. 2017;55: 175–176. doi: https://doi.org/10.1016/j.neurobiolaging.2017.03.028 CrossRefGoogle Scholar
  14. 14.
    Lövdén M, Bäckman L, Lindenberger U, Schaefer S, Schmiedek F. A theoretical framework for the study of adult cognitive plasticity. Psychological Bulletin. 2010;136: 659–676. doi: https://doi.org/10.1037/a0020080 CrossRefGoogle Scholar
  15. 15.
    Cespón J, Miniussi C, Pellicciari MC. Interventional programmes to improve cognition during healthy and pathological ageing: Cortical modulations and evidence for brain plasticity. Ageing Research Reviews. 2018;43: 81–98. doi: https://doi.org/10.1016/j.arr.2018.03.001 CrossRefGoogle Scholar
  16. 16.
    Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385: 2255–2263. doi: https://doi.org/10.1016/S0140-6736(15)60461-5 CrossRefGoogle Scholar

Copyright information

© Serdi and Springer Nature Switzerland AG 2019

Authors and Affiliations

  • David D. Ward
    • 1
    Email author
  • M. J. Summers
    • 1
    • 2
  • M. J. Valenzuela
    • 3
  • V. K. Srikanth
    • 4
    • 5
    • 6
  • J. J. Summers
    • 7
    • 8
  • A. E. King
    • 1
  • K. Ritchie
    • 9
    • 10
  • A. L. Robinson
    • 1
  • J. C. Vickers
    • 1
  1. 1.Wicking Dementia Research & Education CentreUniversity of TasmaniaHobartAustralia
  2. 2.Sunshine Coast Mind and Neuroscience — Thompson InstituteUniversity of the Sunshine CoastBirtinyaAustralia
  3. 3.Regenerative Neuroscience Group, Brain and Mind Research InstituteUniversity of SydneyCamperdownAustralia
  4. 4.Peninsula Clinical School, Central Clinical SchoolMonash UniversityMelbourneAustralia
  5. 5.Peninsula Health, Department of MedicineMelbourneAustralia
  6. 6.Menzies Institute for Medical ResearchUniversity of TasmaniaHobartAustralia
  7. 7.Research Institute for Sport and Exercise SciencesLiverpool John Moores UniversityLiverpoolUK
  8. 8.University of TasmaniaHobartAustralia
  9. 9.Inserm, U1061 Neuropsychiatry: Epidemiological and Clinical ResearchLa Colombiere HospitalMontpellierFrance
  10. 10.Centre for Clinical Brain SciencesUniversity of EdinburghEdinburghUK

Personalised recommendations